Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 12.97%1.31T | 17.86%956.8B | 19.28%657.74B | 15.78%301.08B | 6.84%1.16T | 4.27%811.83B | 3.87%551.45B | 7.04%260.05B | 3.67%1.08T | 3.70%778.59B |
| Operating income | 12.97%1.31T | 17.86%956.8B | 19.28%657.74B | 15.78%301.08B | 6.84%1.16T | 4.27%811.83B | 3.87%551.45B | 7.04%260.05B | 3.67%1.08T | 3.70%778.59B |
| Cost of sales | -12.73%-1.1T | -17.73%-801.84B | -18.79%-553.25B | -14.96%-253.23B | -5.40%-974.95B | -2.82%-681.08B | -2.71%-465.74B | -6.45%-220.28B | -2.87%-924.96B | -2.65%-662.38B |
| Operating expenses | -12.73%-1.1T | -17.73%-801.84B | -18.79%-553.25B | -14.96%-253.23B | -5.40%-974.95B | -2.82%-681.08B | -2.71%-465.74B | -6.45%-220.28B | -2.87%-924.96B | -2.65%-662.38B |
| Gross profit | 14.23%210.03B | 18.52%154.96B | 21.91%104.49B | 20.31%47.85B | 15.13%183.87B | 12.52%130.75B | 10.66%85.71B | 10.42%39.77B | 8.59%159.7B | 10.11%116.2B |
| Selling expenses | -75.07%-83.95B | -88.32%-58.61B | -77.81%-37.56B | -13.93%-10.54B | -19.49%-47.95B | -15.16%-31.12B | -10.77%-21.12B | -15.60%-9.25B | -6.25%-40.13B | -4.79%-27.02B |
| Administrative expenses | -34.79%-11.98B | -34.77%-8.67B | -38.27%-5.68B | -22.17%-2.41B | 8.47%-8.89B | 12.27%-6.43B | 15.46%-4.11B | 20.99%-1.98B | 12.15%-9.71B | 1.01%-7.33B |
| Research and development expenses | -30.52%-22.23B | -23.08%-15.57B | -20.23%-9.92B | -14.55%-4.62B | -3.89%-17.03B | -4.94%-12.65B | 0.08%-8.25B | 3.63%-4.03B | 2.96%-16.39B | 3.79%-12.05B |
| Profit from asset sales | -74.66%387M | --387M | --224M | ---- | -33.11%1.53B | ---- | ---- | ---- | 65.55%2.28B | 20.50%1.48B |
| Impairment and provision | 44.81%-1.3B | ---- | ---- | ---- | 54.32%-2.36B | ---- | ---- | ---- | ---5.17B | ---- |
| -Goodwill impairment | -63.08%-1.3B | ---- | ---- | ---- | 74.58%-799M | ---- | ---- | ---- | ---3.14B | ---- |
| -Other impairment is provision | ---- | ---- | ---- | ---- | 22.86%-1.56B | ---- | ---- | ---- | ---2.03B | ---- |
| Special items of operating profit | -25.20%-88.18B | -26.99%-63.88B | -23.08%-41.88B | -17.44%-19.74B | -9.09%-70.43B | -6.41%-50.31B | -6.17%-34.03B | -9.34%-16.81B | -2.46%-64.56B | -2.44%-47.28B |
| Operating profit | -92.84%2.77B | -71.49%8.62B | -46.85%9.67B | 36.79%10.53B | 48.84%38.74B | 26.02%30.25B | 23.84%18.2B | 19.81%7.7B | 31.95%26.03B | 61.13%24B |
| Financing cost | 3.21%-2.8B | -0.15%-1.97B | 3.57%-1.24B | 0.17%-600M | -0.52%-2.9B | -0.82%-1.97B | -3.62%-1.29B | -1.86%-601M | -36.80%-2.88B | -38.78%-1.95B |
| Special items of earning before tax | 61.50%25.35B | 71.89%20.02B | 49.44%11.61B | 73.40%3.41B | 84.55%15.7B | 84.96%11.65B | 90.00%7.77B | -0.25%1.97B | 326.83%8.51B | 283.29%6.3B |
| Earning before tax | -50.87%25.32B | -33.19%26.67B | -18.80%20.04B | 47.18%13.34B | 62.84%51.54B | 40.86%39.92B | 40.70%24.68B | 16.10%9.07B | 128.24%31.65B | 182.00%28.34B |
| Tax | 68.29%-2.18B | 62.39%-2.31B | 44.84%-2.05B | -21.35%-2.06B | 18.05%-6.88B | 12.44%-6.13B | 15.79%-3.72B | -5.66%-1.7B | -100.98%-8.39B | -95.45%-7B |
| After-tax profit from continuing operations | -48.18%23.14B | -27.89%24.37B | -14.18%17.99B | 53.14%11.28B | 92.03%44.66B | 58.33%33.8B | 59.72%20.96B | 18.81%7.37B | 139.99%23.26B | 229.91%21.35B |
| Earning after tax | -48.18%23.14B | -27.89%24.37B | -14.18%17.99B | 53.14%11.28B | 92.03%44.66B | 58.33%33.8B | 59.72%20.96B | 18.81%7.37B | 139.99%23.26B | 229.91%21.35B |
| Minority profit | 6.36%3.51B | -11.61%2.03B | -22.36%920M | 65.53%389M | 462.75%3.3B | 304.06%2.29B | 323.21%1.19B | 479.03%235M | -32.08%-910M | 164.58%567M |
| Profit attributable to shareholders | -52.54%19.63B | -29.08%22.34B | -13.68%17.07B | 52.73%10.89B | 71.14%41.36B | 51.63%31.51B | 53.98%19.77B | 13.88%7.13B | 132.82%24.17B | 182.77%20.78B |
| Basic earnings per share | -50.18%6.89 | -25.19%7.81 | -7.61%5.95 | 64.91%3.76 | 79.84%13.83 | 57.94%10.44 | 57.46%6.44 | 14.57%2.28 | 131.63%7.69 | 181.28%6.61 |
| Diluted earnings per share | -51.97%6.45 | -27.48%7.39 | -10.41%5.68 | 58.15%3.59 | 76.48%13.43 | 55.81%10.19 | 56.93%6.34 | 15.82%2.27 | 137.07%7.61 | 194.59%6.54 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu Limited, PricewaterhouseCoopers | -- | -- | -- | Deloitte Touche Tohmatsu Limited, PricewaterhouseCoopers | -- | -- | -- | Deloitte Touche Tohmatsu Limited, PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.